Global Intravenous Solutions Market Report and Forecast 2024-2032

Global Intravenous Solutions Market Outlook

The growth of the global intravenous solutions market is being driven by the rising prevalence of the chronic diseases across the globe. The market value was 13.03 billion in 2023 and it is anticipated to grow at a CAGR of 7.2% during the forecast period of 2024-2032. The global intravenous solutions market is anticipated to achieve a value of USD 24.26 billion by 2032.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

North America, with the bulk of the overall market share, is the dominant market for intravenous solutions. The regional market is being driven by the rapid development of the United States manufacturing capacity owing to a shortage of IV fluids. Moreover, developing countries, including India and China, are increasing their investments in the health sector, which is likely to boost the demand for intravenous solutions. Additionally, manufacturers are implementing new product technologies like offering premixed options for greater convenience and reducing packaging waste.

The development of IV fluids has seen tremendous growth, especially in developed countries. For example, it has been stated that the US Food and Drug Administration (FDA) and other market players are making efforts to alleviate the crisis because of the scarcity of IV saline. In relation to this, Merge, a US-based marketing and development organisation, collaborated with the ground-breaking provider of medical products and services, B. Braun Medical, to launch omnichannel campaign 'Solutions for Life' in May 2020. This programme seeks to ensure an effective supply of IV solutions, approved by the United States FDA.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Properties and Applications

Intravenous (IV) solutions refer to a complete mixture of vital nutrients intended to refill fluid losses, treat electrolyte imbalances as well as maintain fluid balance in intravenous therapy. It also provides the patients suffering from diabetes, cancer, and other diseases with the necessary nutrients. Intravenous solutions can contain water incorporated in concentrations with electrolytes, sugar, or medicines, as prescribed by the patient. In accordance with this, these solutions differ in rate and quantity, relying on the patient's medical condition, age, as well as body size.

Based on type, the market can be divided into the following:

• Partial Parenteral Nutrition
• Total Parenteral Nutrition

On the basis of nutrients, the industry can be segmented as follows:

• Carbohydrates
• Salts and Electrolytes
• Minerals
• Vitamins
• Amino Acids

The regional markets for intravenous solutions include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Market Analysis

Owing to unhealthy dietary habits, there has been a rise in disease prevalence, including gastrointestinal disorder, neurological disorders, cancer, and diabetes, which is the main factor contributing to the development of the intravenous solutions market. In fact, since these options are available in compact packets, it is safer for patients to use the drips at the convenience of their home rather than hospitals. In addition, developing countries, including India and China, are increasing their investment in the health sector that is likely to boost the demand for intravenous solutions. Additionally, manufacturers are implementing new product technologies like offering premixed options for greater convenience and reducing packaging waste.

Competitive Landscape 

The report gives a detailed analysis of the following companies in the global intravenous solutions market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:

• Ajinomoto Health & Nutrition North America, Inc. 
• B. Braun Medical Inc.
• ICU Medical, Inc.
• Baxter International, Inc. 
• Others

The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.

Key Highlights of the Report